180 related articles for article (PubMed ID: 16441232)
1. Adipose targets for obesity drug development.
Boss O; Bergenhem N
Expert Opin Ther Targets; 2006 Feb; 10(1):119-34. PubMed ID: 16441232
[TBL] [Abstract][Full Text] [Related]
2. Emerging antiobesity drugs.
Spanswick D; Lee K
Expert Opin Emerg Drugs; 2003 May; 8(1):217-37. PubMed ID: 14610923
[TBL] [Abstract][Full Text] [Related]
3. Emerging pharmacological approaches to the treatment of obesity.
Wasan KM; Looije NA
J Pharm Pharm Sci; 2005 Aug; 8(2):259-71. PubMed ID: 16124937
[TBL] [Abstract][Full Text] [Related]
4. Obesity pharmacotherapy: current perspectives and future directions.
Misra M
Curr Cardiol Rev; 2013 Feb; 9(1):33-54. PubMed ID: 23092275
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of obesity: targets and perspectives.
Chiesi M; Huppertz C; Hofbauer KG
Trends Pharmacol Sci; 2001 May; 22(5):247-54. PubMed ID: 11339976
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical approaches to the treatment of obesity.
Jandacek RJ; Woods SC
Drug Discov Today; 2004 Oct; 9(20):874-80. PubMed ID: 15475320
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.
Cao Y
Nat Rev Drug Discov; 2010 Feb; 9(2):107-15. PubMed ID: 20118961
[TBL] [Abstract][Full Text] [Related]
8. Treating obesity: pharmacology of energy expenditure.
Clapham JC
Curr Drug Targets; 2004 Apr; 5(3):309-23. PubMed ID: 15058315
[TBL] [Abstract][Full Text] [Related]
9. A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.
Hossen N; Kajimoto K; Akita H; Hyodo M; Harashima H
J Control Release; 2013 Oct; 171(2):104-12. PubMed ID: 23871959
[TBL] [Abstract][Full Text] [Related]
10. Strategies and potential molecular targets for obesity treatment.
Campfield LA; Smith FJ; Burn P
Science; 1998 May; 280(5368):1383-7. PubMed ID: 9603722
[TBL] [Abstract][Full Text] [Related]
11. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
Schinzari F; Tesauro M; Cardillo C
J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
[TBL] [Abstract][Full Text] [Related]
12. Medicinal strategies in the treatment of obesity.
Bray GA; Tartaglia LA
Nature; 2000 Apr; 404(6778):672-7. PubMed ID: 10766254
[TBL] [Abstract][Full Text] [Related]
13. Are stimulators of fat oxidation interesting drug discovery targets?
Levens N
Curr Opin Investig Drugs; 2005 Apr; 6(4):363. PubMed ID: 15898341
[No Abstract] [Full Text] [Related]
14. Anti-obesity drug development.
Bays H; Dujovne C
Expert Opin Investig Drugs; 2002 Sep; 11(9):1189-204. PubMed ID: 12225242
[TBL] [Abstract][Full Text] [Related]
15. Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice.
Chang HP; Wang ML; Chan MH; Chiu YS; Chen YH
Nutrition; 2011 Apr; 27(4):463-70. PubMed ID: 21392705
[TBL] [Abstract][Full Text] [Related]
16. The role of leptin and hypothalamic neuropeptides in energy homeostasis: update on leptin in obesity.
Mantzoros CS
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S85-9. PubMed ID: 11527094
[TBL] [Abstract][Full Text] [Related]
17. Delivery of miRNAs to the adipose organ for metabolic health.
Kornmueller K; Amri EZ; Scheideler M; Prassl R
Adv Drug Deliv Rev; 2022 Feb; 181():114110. PubMed ID: 34995679
[TBL] [Abstract][Full Text] [Related]
18. Shp2 as a therapeutic target for leptin resistance and obesity.
Feng GS
Expert Opin Ther Targets; 2006 Feb; 10(1):135-42. PubMed ID: 16441233
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.
Assadi-Porter FM; Reiland H; Sabatini M; Lorenzini L; Carnicelli V; Rogowski M; Selen Alpergin ES; Tonelli M; Ghelardoni S; Saba A; Zucchi R; Chiellini G
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786646
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Carriers for Controlled Drug Delivery in Obesity Treatment.
Huang D; Deng M; Kuang S
Trends Endocrinol Metab; 2019 Dec; 30(12):974-989. PubMed ID: 31668904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
